Business · 14/05/2014Updated: 10/17/2026 · 1 min read
FzioMed, Incorporated Files Petition for Review of FDA's Denial of Premarket Approval for Oxiplex®/SP Gel
Summary
FzioMed, Incorporated has submitted a petition for review of the FDA's denial of premarket approval for its Oxiplex®/SP Gel, and has scheduled a meeting to discuss the matter further.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →